Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005681 | spliceosomal complex | 3 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: A4HGZ9
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0030627 | pre-mRNA 5'-splice site binding | 6 | 1 |
GO:0036002 | pre-mRNA binding | 5 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 125 | 129 | PF00656 | 0.379 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.426 |
CLV_PCSK_PC1ET2_1 | 144 | 146 | PF00082 | 0.407 |
CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 248 | 252 | PF00082 | 0.352 |
CLV_PCSK_SKI1_1 | 52 | 56 | PF00082 | 0.540 |
DEG_SPOP_SBC_1 | 230 | 234 | PF00917 | 0.437 |
DEG_SPOP_SBC_1 | 4 | 8 | PF00917 | 0.427 |
DOC_MAPK_gen_1 | 144 | 151 | PF00069 | 0.445 |
DOC_MAPK_MEF2A_6 | 292 | 301 | PF00069 | 0.350 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.304 |
DOC_USP7_MATH_1 | 230 | 234 | PF00917 | 0.543 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.326 |
DOC_USP7_MATH_1 | 75 | 79 | PF00917 | 0.282 |
LIG_14-3-3_CanoR_1 | 211 | 216 | PF00244 | 0.523 |
LIG_Actin_WH2_2 | 89 | 105 | PF00022 | 0.380 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.411 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.326 |
LIG_BRCT_BRCA1_1 | 128 | 132 | PF00533 | 0.369 |
LIG_CSL_BTD_1 | 255 | 258 | PF09270 | 0.381 |
LIG_FHA_1 | 199 | 205 | PF00498 | 0.392 |
LIG_FHA_1 | 39 | 45 | PF00498 | 0.386 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.494 |
LIG_FHA_2 | 123 | 129 | PF00498 | 0.366 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.353 |
LIG_LIR_Gen_1 | 164 | 174 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 115 | 119 | PF02991 | 0.306 |
LIG_LIR_Nem_3 | 16 | 22 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 164 | 170 | PF02991 | 0.469 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.432 |
LIG_SH2_GRB2like | 19 | 22 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.385 |
LIG_SH2_STAT5 | 307 | 310 | PF00017 | 0.351 |
LIG_SH3_3 | 152 | 158 | PF00018 | 0.486 |
LIG_SH3_3 | 201 | 207 | PF00018 | 0.330 |
LIG_SH3_3 | 260 | 266 | PF00018 | 0.451 |
LIG_SUMO_SIM_anti_2 | 45 | 51 | PF11976 | 0.297 |
LIG_TYR_ITIM | 17 | 22 | PF00017 | 0.252 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.377 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.487 |
MOD_CK1_1 | 77 | 83 | PF00069 | 0.339 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.506 |
MOD_GlcNHglycan | 160 | 163 | PF01048 | 0.430 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.433 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.538 |
MOD_GlcNHglycan | 266 | 269 | PF01048 | 0.398 |
MOD_GlcNHglycan | 294 | 297 | PF01048 | 0.355 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.545 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.448 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.412 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.324 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.444 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.330 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.402 |
MOD_GSK3_1 | 5 | 12 | PF00069 | 0.349 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.304 |
MOD_N-GLC_1 | 297 | 302 | PF02516 | 0.431 |
MOD_NEK2_1 | 217 | 222 | PF00069 | 0.385 |
MOD_NEK2_1 | 223 | 228 | PF00069 | 0.382 |
MOD_NEK2_1 | 229 | 234 | PF00069 | 0.409 |
MOD_NEK2_1 | 297 | 302 | PF00069 | 0.431 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.305 |
MOD_NEK2_2 | 165 | 170 | PF00069 | 0.236 |
MOD_NEK2_2 | 284 | 289 | PF00069 | 0.546 |
MOD_PIKK_1 | 123 | 129 | PF00454 | 0.243 |
MOD_PIKK_1 | 205 | 211 | PF00454 | 0.550 |
MOD_PIKK_1 | 223 | 229 | PF00454 | 0.464 |
MOD_PKB_1 | 101 | 109 | PF00069 | 0.473 |
MOD_Plk_1 | 297 | 303 | PF00069 | 0.444 |
MOD_Plk_4 | 126 | 132 | PF00069 | 0.365 |
MOD_Plk_4 | 199 | 205 | PF00069 | 0.329 |
MOD_Plk_4 | 259 | 265 | PF00069 | 0.277 |
MOD_Plk_4 | 271 | 277 | PF00069 | 0.270 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.450 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.410 |
TRG_DiLeu_BaEn_1 | 247 | 252 | PF01217 | 0.492 |
TRG_DiLeu_BaLyEn_6 | 233 | 238 | PF01217 | 0.364 |
TRG_ENDOCYTIC_2 | 19 | 22 | PF00928 | 0.438 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5J8 | Leptomonas seymouri | 61% | 100% |
A0A1X0NQJ3 | Trypanosomatidae | 37% | 100% |
A0A3S7X1X9 | Leishmania donovani | 85% | 72% |
A0A422NG23 | Trypanosoma rangeli | 39% | 100% |
A4I431 | Leishmania infantum | 85% | 100% |
D0A8X8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 99% |
E9B0B8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
O94620 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 95% |
Q4Q7W6 | Leishmania major | 87% | 100% |
V5BDN5 | Trypanosoma cruzi | 39% | 100% |